Diane K. Sheehan
Ufficiale delle Risorse Umane presso CADENCE PHARMACEUTICALS, INC.
Profilo
Diane K.
Sheehan is currently the Vice President-Human Resources at Mallinckrodt Hospital Products, Inc. She previously worked as the Director-Compensation at Elan Pharmaceuticals, LLC from 2003 to 2006.
She obtained both her undergraduate and graduate degrees from San Diego State University.
Posizioni attive di Diane K. Sheehan
| Società | Posizione | Inizio |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/05/2006 |
Precedenti posizioni note di Diane K. Sheehan
| Società | Posizione | Fine |
|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2006 |
Formazione di Diane K. Sheehan
| San Diego State University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
- Borsa valori
- Insiders
- Diane K. Sheehan
